This program is composed of 75 participating methadone treatment programs. Patients who are enrolling at these treatment centers are asked to complete an anonymous questionnaire, which includes questions concerning the patient’s drugs of choice, drug use in the past month, lifetime drug abuse, age at first use, and the primary source of the abused drugs. Cases are defined as self-reported use of a prescription or illicit opioid to get high in the past 30 days. Cases are assigned to the reported 3-digit ZIP code of the patient’s residence.

The study is under the direction of Andrew Rosenblum, Ph.D., National Development and Research Institutes, Inc. (NDRI) in New York City, NY, and Mark Parrino, M.P.A., American Association for the Treatment of Opioid Dependence (AATOD) in New York City, NY. Other key personnel include Chunki Fong, M.S., from NDRI and Carleen Maxwell, M.P.H., from AATOD.